Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Latest action · Jun 20, 2018 Received in the Senate and Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 24, 2018
- Passed HouseJun 19, 2018
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access to opioid-use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.
Opioid-use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participants.
(Sec. 3) The bill also requires prescriptions for controlled substances that are covered under the Medicare prescription drug benefit or Medicare Advantage prescription drug plans to be transmitted via electronic prescription programs. The CMS may waive such requirements under specified circumstances.
Cosponsors 2
Members who signed on, in the order they did. All signed on May 24, 2018.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-OR | Greg Walden | May 24, 2018 | |
| R-TN | Marsha Blackburn | May 24, 2018 |
Actions 16
Everything that happened, newest first.
- Jun 20, 2018Received in the Senate and Read twice and referred to the Committee on Finance.
- Jun 19, 2018Considered under suspension of the rules. (consideration: CR H5239-5243)
- Jun 19, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 5605.
- Jun 19, 2018Motion to reconsider laid on the table Agreed to without objection.
- Jun 19, 2018Mr. Walden moved to suspend the rules and pass the bill, as amended.
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 6 | SUPPORT for Patients and Communities Act | Related bill | Oct 24, 2018 |
| S 2460 | Every Prescription Conveyed Securely Act | Related bill | Feb 27, 2018 |
| HR 3528 | Every Prescription Conveyed Securely Act | Related bill | Jun 12, 2018 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Congressional oversight
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Government studies and investigations
- Health
- Health care quality
- Health personnel
- Health programs administration and funding
- Home and outpatient care
- Hospital care
- Medicare
- Mental health
- Performance measurement
- Prescription drugs
- User charges and fees
Text 4
Each version as it was printed, newest first.
- Jun 20, 2018Referred in Senate
- Jun 19, 2018Engrossed in House
- Jun 12, 2018Reported in House
- Apr 24, 2018Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.